Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors

Brown, Jean K.; Byers, Tim; Thompson, Kevin J.; Eldridge, Barbara; Doyle, Colleen; Williams, Alexis

doi:10.3322/canjclin.51.3.153

Cited by 101 publications

(70 citation statements)

References 125 publications

(192 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These differences in energy may be due to differences in the socioeconomic status or lack of awareness about the type of diet provided to breast cancer patients having chemotherapy doses (Harvie, et al 2005).The intake of fat and cholesterol were lower than the recommended dietary allowances (RDA), similar study in agreement with the present study which found that, fat intake was reduced among breast cancer patients undergoing chemotherapy (Brown, et al 2001), while another study showed that women who received chemotherapy treatment had increased levels of cholesterol ( Bing, et al2004). Significant correlation was detected between energy intake (P=0.001) with chemotherapy doses and no correlation was detected between fat intake (p=0.550), cholesterol (p= 0.781) with chemotherapy doses.…”

Section: Discussionsupporting

confidence: 89%

Assessment of Dietary Intake in Patients with Breast Cancer Receiving Chemotherapy

2015

IJSR

View full text Add to dashboard Cite

Chemotherapy is the most common treatment for the breast cancer in women. Appetite, diet and the nutritional nutrients may change when patients undergoing chemotherapy treatment. This Cross-sectional hospital based study was carried out to assess the dietary intake and the effects of chemotherapy dosage on the nutritional status of 276 females who were diagnosed with cancer and are undergoing chemotherapy in Radiation and Isotopes Center Khartoum (RICK). The participants in this study were selected randomly. Data was collected using questionnaire and 24 hour recall that were filled and administered by the researcher through interviews with breast cancer patients. The collected data was analyzed using computerized methods of analysis (SPSS) and (Nutri-survey 2007). The results indicated that, the majority of participants in the present study were lived in Khartoum state, their age varied between 30-50 years old. The 24 hours recall demonstrated that energy intake among the participants was lower than the Recommended Dietary Allowances (RDA).The intake of fat, cholesterol, and fiber among the participants was also lower than the recommended dietary allowances (RDA), while intake of carbohydrates and protein among them was more than the RDA. The intake of vitamins (A, E, C) was less than RDA. The intake of B vitamin among the participants, including B1, B2, B6 and folic acid was less than RDA. Minerals intake which included Sodium, potassium, calcium, magnesium and zinc, was less than the RDA, while the intake of phosphorus and iron was more than RDA. Significant correlations was found between energy intake (p=0.001), carbohydrate intake (p=0.024), B2 intake (p=0.007), (zinc intake (p=0.027) and magnesium intake (p=0.002) with chemotherapy dosage among the participants. The study recommended that, early nutrition interventions and education play an important role in improving the nutrition status and quality of life of breast cancer patients.

show abstract

Section: Discussionsupporting

confidence: 89%

Assessment of Dietary Intake in Patients with Breast Cancer Receiving Chemotherapy

2015

IJSR

View full text Add to dashboard Cite

show abstract

“…2 It builds on the first report published in 2001 by including more information on physical activity and by adding new evidence from research published in the past 3 years. In addition to a review of the current scientific evidence and best clinical practices, the Expert Committee has also provided summary tables grading both the quality and certainty of the scientific evidence for selected factors affecting common cancers.…”

Section: Overview Of the Reportmentioning

confidence: 99%

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

Brown

Byers

Doyle

et al. 2003

CA: A Cancer Journal for Clinicians

Self Cite

276

202

View full text Add to dashboard Cite

Cancer survivors are often highly motivated to seek information about food choices, physical activity, dietary supplement use, and complementary nutritional therapies to improve their treatment outcomes, quality of life, and survival. To address these concerns, the American Cancer Society (ACS) convened a group of experts in nutrition, physical activity, and cancer to evaluate the scientific evidence and best clinical practices related to optimal nutrition and physical activity after the diagnosis of cancer. This report summarizes their findings and is intended to present health care providers with the best possible information on which to help cancer survivors and their families make informed choices related to nutrition and physical activity. The report discusses nutrition and physical activity issues during the phases of cancer treatment and recovery, living after recovery from treatment, and living with advanced cancer; selected nutritional and physical activity issues such as body weight, food choices, and complementary and alternative nutritional options; and selected issues related to breast, colorectal, lung, prostate, head and neck, and upper gastrointestinal cancers. In addition, handouts containing commonly asked questions and answers and a resource list are provided for survivors and families. Tables that grade the scientific evidence for benefit versus harm related to nutrition and physical activity for breast, colorectal, lung, and prostate cancers are also included for this growing body of knowledge to provide guidance for informed decision making and to identify areas for future research. (CA Cancer J Clin 2003;53:268 -291.)

show abstract

“…There are no clear dietary [17] and/or lifestyle [18] factors associated with the prevention or treatment of primary low-grade gliomas [19].…”

Section: Treatmentmentioning

confidence: 99%

Low-grade gliomas

Stieber

2001

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

Low-grade gliomas are uncommon primary brain tumors classified as histologic grades I or II in the World Health Organization (WHO) classification. The most common variants are pilocytic and low-grade astrocytomas, oligodendrogliomas, and mixed oligo-astrocytomas located in the cerebral hemispheres. Prognostic factors that predict progression-free and overall survival include young age, pilocytic histology, good Karnofsky performance status, gross total resection, lack of enhancement on imaging, and small preoperative tumor volumes. Edema and vasogenic effects are typically managed with corticosteroids. Dexamethasone is given at an initial dosage of 4 mg given four times daily. Anticonvulsants are given prophylactically after resection and for patients who present with seizures. The rationale for open craniotomy depends on the need for immediate palliation of symptoms by reduction of intracranial pressure or focal mass effect, and/or improved oncologic control. Gross total resection of tumor is generally defined as the absence of residual enhancement on contrast-enhanced postoperative MRI scan. Most retrospective studies suggest that patients who have undergone a gross total resection of tumor have improved survival. Depending upon the proximity of the tumor to eloquent brain, gross total resection may or may not be possible. In these cases a stereotactic biopsy is required to provide the histologic diagnosis. Adjuvant radiotherapy is recommended for patients with incompletely resected grade II tumors or for patients older than age 40 regardless of extent of resection. It may be considered for any pilocytic astrocytoma from which a biopsy has been performed. Phase III randomized prospective trials have shown statistically significantly improved progression-free survival at 5 years with the addition of radiotherapy, though overall survival does not appear different. Based on prospective randomized phase III trials, 50.4 Gy to 54 Gy of conventionally fractionated radiotherapy appears to be a safe and effective regimen with minimal neurotoxicity; 45 Gy may be adequate for biopsied pilocytic astrocytomas. Currently, RTOG trial 98-02 is investigating the efficacy of postradiation PCV chemotherapy (procarbazine, CCNU, and vincristine) in the treatment of newly diagnosed unfavorable low-grade gliomas. Other areas of investigation include Temozolomide chemotherapy and the association of 1p and 19q chromosomal deletions with prolonged survival in oligodendrogliomas and sensitivity to PCV chemotherapy. Radiosurgery and/or experimental chemotherapy may provide some measure of local control in the recurrent disease setting.

show abstract

Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors

Cited by 101 publications

References 125 publications

Assessment of Dietary Intake in Patients with Breast Cancer Receiving Chemotherapy

Assessment of Dietary Intake in Patients with Breast Cancer Receiving Chemotherapy

Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices

Low-grade gliomas

Contact Info

Product

Resources

About